Type
1.
Leal DR, Cazarin G, Bezerra LCA, Albuquerque AC, Felisberto E. [Leprosy Control Program: assessment of implementation in districts]. Saúde em debate [Internet]. 2017;41(Especial):209-28. Available from: http://www.scielo.br/scielo.php?pid=S0103-11042017000500209&script=sci_arttext
Type
1.
Kumar S. India resurrects forgotten leprosy vaccine. Science (New York, N.Y.). 2017;356(6342):999.
Type
1.
Rodrigues RWP, Ribeiro AB, Berber GCM, Sheng L, Damazo AS. Analysis of clinical data and T helper 1/T helper 2 responses in patients with different clinical forms of leprosy. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2017;50(2):208-15. Available from: http://www.scielo.br/pdf/rsbmt/v50n2/0037-8682-rsbmt-50-02-00208.pdf
Type
1.
Araujo S, Goulart LR, Truman RW, Goulart IM, Vissa V, Li W, et al. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients. PLoS neglected tropical diseases [Internet]. 2017;11(6):e0005506. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0005506&type=printable
Type
1.
Bichara CNC, Bichara CDA, Tostes C, Povoa MM, Quaresma JAS, Xavier MB. Prevalence of autoantibodies against cellular antigens in patients with HIV and leprosy coinfection in the Amazon region. Infectious diseases of poverty [Internet]. 2017;6(1):80. Available from: http://tinyurl.com/yavhtrkp
Type
1.
Long S. Barriers to prevent disability due to leprosy in children are breachable. The Journal of pediatrics [Internet]. 2017;185:3. Available from: http://www.jpeds.com/article/S0022-3476(17)30499-7/pdf
Type
1.
Keed A. Leprosy: a forgotten disease? Medicine today. 2017;18(5):61-6.
Type
1.
Ghunawat S, Relhan V, Garg V. A 10-year retrospective analysis of leprosy cases in a hospital setup in India: Scenario in post MDT era. Journal of the American Academy of Dermatology. 2017;76(6):AB2.
Type
1.
Pouldar D, Teles R, Modlin R. PLAU and SerpinB2 role in apoptosis in leprosy. Journal of the American Academy of Dermatology. 2017;76(6):AB199.
Type
1.
M R Teixeira M, B Assunção C, R Gomes R, Rocha-Silva F, M de Figueiredo S, R R Teixeira E, et al. A case of subcutaneous phaeohyphomycosis associated with leprosy. Infectious disorders drug targets. 2017;
Pagination
- Previous page
- Page 226
- Next page